Role of oxMIF in Innate and Adaptive Immunity with OncoOne CBO, Brent Meadows
OncoOne is a biotech company developing novel therapeutics for patients with solid tumors and autoimmune diseases. In this podcast episode, Brent Meadows, Chief Business Officer and US General Manager, discusses the role of oxMIF in innate and adaptive immunity and outlines the company's development approach and plan for entering the clinic.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.